[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Get all the relevant market information you need — get it fast, on time, and accurately with Barchart Plus. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Charles River Laboratories Intl (CRL)

Charles River Laboratories Intl (CRL)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 8,764,124
  • Shares Outstanding, K 49,342
  • Annual Sales, $ 4,015 M
  • Annual Income, $ -144,340 K
  • EBIT $ 580 M
  • EBITDA $ 1,149 M
  • 60-Month Beta 1.44
  • Price/Sales 2.23
  • Price/Cash Flow 8.28
  • Price/Book 3.04

Options Overview Details

View History
  • Implied Volatility 44.60% (-0.48%)
  • Historical Volatility 50.89%
  • IV Percentile 48%
  • IV Rank 31.53%
  • IV High 71.52% on 02/17/26
  • IV Low 32.21% on 06/18/25
  • Expected Move (DTE 5) 6.33 (3.57%)
  • Put/Call Vol Ratio 0.22
  • Today's Volume 260
  • Volume Avg (30-Day) 161
  • Put/Call OI Ratio 0.65
  • Today's Open Interest 5,296
  • Open Int (30-Day) 4,709
  • Expected Range 171.29 to 183.95

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 16 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $2.71
  • Number of Estimates 8
  • High Estimate $3.00
  • Low Estimate $2.47
  • Prior Year $3.12
  • Growth Rate Est. (year over year) -13.14%

Price Performance

See More
Period Period Low Period High Performance
1-Month
161.95 +9.68%
on 04/30/26
194.57 -8.71%
on 05/07/26
+2.55 (+1.46%)
since 04/08/26
3-Month
146.33 +21.38%
on 02/18/26
194.57 -8.71%
on 05/07/26
-11.59 (-6.13%)
since 02/06/26
52-Week
132.58 +33.97%
on 06/02/25
228.88 -22.40%
on 01/13/26
+36.26 (+25.65%)
since 05/08/25

Most Recent Stories

More News
CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

CRL Q1 Deep Dive: Portfolio Restructuring and Cost Initiatives Set Stage for Margin Expansion

CRL : 177.62 (-2.23%)
Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations

Charles River Laboratories (NYSE:CRL) Exceeds Q1 CY2026 Expectations

CRL : 177.62 (-2.23%)
Charles River: Q1 Earnings Snapshot

Charles River: Q1 Earnings Snapshot

CRL : 177.62 (-2.23%)
Charles River Laboratories Announces First-Quarter 2026 Results

– Reports First-Quarter Revenue of $995.8 Million, GAAP Loss per Share of $(0.30), and Non-GAAP Earnings per Share of $2.06 – – Reaffirms 2026 Guidance...

CRL : 177.62 (-2.23%)
Charles River's Leaner Portfolio Thesis Meets Its First Real Scrutiny Tomorrow

Barchart Research What to Expect from CRL Earnings CRL Generated May 6, 2026 Current Price $181.73 EPS Estimate $$1.96 Consensus Rating Moderate Buy Average Move 8.77% Charles River's Leaner Portfolio...

CRL : 177.62 (-2.23%)
Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

Charles River Laboratories (CRL) To Report Earnings Tomorrow: Here Is What To Expect

CRL : 177.62 (-2.23%)
Charles River Launches Rat In Vitro Fertility Services Demonstrating Embryology Capabilities

As the first commercial provider to deliver in vitro fertility services for rat models, Company demonstrates commitment to the 3Rs

CRL : 177.62 (-2.23%)
3 Healthcare Stocks We Keep Off Our Radar

3 Healthcare Stocks We Keep Off Our Radar

REGN : 714.89 (+0.82%)
CRL : 177.62 (-2.23%)
AHCO : 11.30 (-3.67%)
1 S&P 500 Stock to Own for Decades and 2 We Find Risky

1 S&P 500 Stock to Own for Decades and 2 We Find Risky

ZBH : 82.33 (-1.25%)
AXP : 316.03 (-0.83%)
CRL : 177.62 (-2.23%)
Charles River Highlights Effectiveness of VCGs in Toxicology

Peer-reviewed evidence supports the use of Virtual Control Groups in nonclinical toxicology studies

CRL : 177.62 (-2.23%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Charles River Laboratories International, Inc. is a full service, early-stage contract research organization. The company provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and leading academic institutions globally accelerate their research...

See More

Key Turning Points

3rd Resistance Point 192.39
2nd Resistance Point 188.02
1st Resistance Point 182.82
Last Price 177.62
1st Support Level 173.24
2nd Support Level 168.87
3rd Support Level 163.67

See More

52-Week High 228.88
Fibonacci 61.8% 192.09
Fibonacci 50% 180.73
Last Price 177.62
Fibonacci 38.2% 169.37
52-Week Low 132.58

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.